Financial Data and Key Metrics Changes - In 2025, the company achieved full-year profitability in airline operations, defined as positive Adjusted EBITDA, marking a significant operational improvement [20][25] - Full-year revenue for 2025 was $106.6 million, an 11% decrease compared to 2024, driven by a 15% decrease in scheduled service revenue, partially offset by a 3% increase in on-demand charter revenue [23][24] - The Adjusted EBITDA loss for 2025 was $41.7 million, a 5% improvement over the previous year's loss of $44.1 million [25] Business Line Data and Key Metrics Changes - The airline operations achieved profitability for the full year of 2025, with controllable completion factors improving to 98% in Q4 2025 from 89% in Q4 2024 [25][26] - The on-demand charter business saw revenue increase and improved flight margins year-over-year, driven by better sourcing discipline and a shift to longer-haul trips with larger aircraft [9][20] - In Q4 2025, on-demand charter revenue increased by 36% year-over-year, while scheduled service revenue decreased by 19% [23][24] Market Data and Key Metrics Changes - The company is focusing on the Hawaii market as a strategic anchor for demonstrating electric aircraft technologies, committing over $22 million to enhance infrastructure and operations [13][14] - The partnership with BETA Technologies aims to introduce electric aircraft into service, with plans for cargo operations starting in 2026 [14][16] Company Strategy and Development Direction - The company is transitioning from an airline-first model to a platform-centric business, emphasizing the integration of electric aircraft and AI-enabled software [30][31] - The strategic partnership with BETA Technologies is expected to enhance operational efficiencies and profitability through the introduction of electric aircraft [14][16] - The company plans to commercialize its SurfOS technology in 2026, targeting enterprise clients and expanding its software offerings [11][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position to lead the next structural transformation in aviation, with a focus on partnerships and electric aircraft collaborations [18][30] - The outlook for 2026 includes anticipated revenue growth of 20%-30% year-over-year, driven by the on-demand charter business and the rollout of SurfOS [28][29] Other Important Information - The company raised over $100 million in equity in 2025 to reduce overall cost of capital and lower net debt, which decreased by 47% to $74 million [4][22] - The company has secured a strategic partnership with BETA Technologies to be the first operator to launch commercial electric aircraft passenger flights in Hawaii [14][16] Q&A Session Summary Question: Clarification on SurfOS spending and commercialization - Management clarified that SurfOS remains a significant investment priority, with a focus on developing BrokerOS and targeting enterprise clients for customized solutions [34][36] Question: Timeline for BETA aircraft integration - Management indicated that the CTOL variant of BETA aircraft will be prioritized for certification and commercial service, with plans for cargo operations in 2026 [37][38] Question: Improvement in economics from BETA aircraft - Management anticipates a 30% reduction in operating costs due to lower fuel and maintenance expenses with the new electric aircraft [39][41] Question: Balance sheet outlook at the end of 2026 - Management noted that significant investments will be made in 2026, but they expect to refine the balance sheet over time to support growth [42][43] Question: Airline operations and future profitability - Management highlighted the importance of technology and electric aircraft adoption for improving profitability in airline operations [46][48] Question: Growth of on-demand charter segment - Management confirmed that the on-demand charter business is the fastest-growing segment, contributing significantly to raised revenue guidance [70][71]

Financial Data and Key Metrics Changes - Revenue for 2025 increased by 20% to approximately $2.2 million, compared to $1.86 million in 2024. Excluding a temporary revenue impact from the transition to managing Amazon sales, full-year revenue growth would have been closer to 30% [6][10] - Gross margin improved to 62.5% in 2025 from 54.1% in 2024, reflecting an improved product mix and a growing contribution from e-commerce channels [10] - The company reported a net loss of $6.4 million in 2025, compared to a net loss of $6.2 million in 2024. Adjusted net loss for the year would have been approximately $5.6 million when excluding one-time legal expenses [10][11] Business Line Data and Key Metrics Changes - E-commerce revenue increased by 88% in 2025, driven by strong growth on Amazon and the direct-to-consumer website, now representing more than half of total revenue [8] - Municipal markets are seeing increased interest in fertility control approaches, with ongoing programs in cities like New York and Chicago [8][9] Market Data and Key Metrics Changes - Internationally, the company expanded its footprint with regulatory approvals in New Zealand and new distribution relationships in Belize [9] - The company is in discussions with potential deployment partners in New York City as the trial of Evolve concludes [9] Company Strategy and Development Direction - The company's core strategy remains focused on scaling current initiatives and maintaining resource allocation discipline while searching for a new CEO [5] - The company aims to accelerate growth in e-commerce, municipal adoption, and technology validation while managing operating expenses carefully [11] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential for growth in 2026, aiming for higher revenue growth rates than in 2025 [13] - The company is focused on maintaining financial discipline while investing in areas with traction, such as e-commerce and municipal markets [11] Other Important Information - The legal dispute with Liphatech has been resolved satisfactorily, with all litigation dismissed [10][22] - The company ended 2025 with $8.6 million in cash and short-term investments, providing a solid operating runway [11] Q&A Session Summary Question: Should we expect similar growth rates in 2026 as in 2025? - Management indicated that growth could be higher, aiming to accelerate growth in profitable areas [13] Question: What will contribute to 2026 revenues? - Revenue will come from a mix of e-commerce, municipal orders, and international expansion [14][15] Question: What is the status of the court case with Liphatech? - The case has been settled satisfactorily, and the company does not expect recurring legal costs related to this issue [22][23] Question: What is the status of product registration in Australia? - Regulatory authorities are expected to provide a response in the spring regarding product registration [25] Question: Will the new CEO have incentives based on stock performance? - Yes, a meaningful portion of the CEO's compensation is expected to be equity-based and aligned with long-term shareholder value [56] Question: How is the agricultural sector performing? - The agricultural sector is performing well, with expansions in various areas including almond groves and poultry [33] Question: Will the company expand its sales team? - Yes, the company plans to expand its sales team to maximize B2B sales efforts [60]

Financial Performance Highlights - The company reported record collections of $245 million, an increase of 41% year-over-year [3][4] - Revenue for the quarter reached $155 million, up 30% compared to the prior year [4][17] - Adjusted EPS for the quarter was $0.69, with adjusted pre-tax income of $51 million, reflecting a 15% year-over-year increase [4][18] - The Cash Efficiency Ratio for the quarter was 71%, driven by strong collections from the Conn's portfolio purchase [4][16] Business Line Performance - Collections from the Conn's portfolio contributed $36 million for the quarter, while the Bluestem portfolio added $14 million [10] - The company achieved record deployments of $381 million, up 6% from the previous year [3][12] - Estimated remaining collections reached $3.4 billion, a 23% increase year-over-year [4][13] Market and Economic Context - Delinquency trends remain elevated across non-mortgage consumer asset classes, creating favorable portfolio supply conditions [5][7] - Personal savings levels have decreased to $831 billion, significantly lower than pre-pandemic averages, indicating limited consumer ability to absorb financial hardships [6] - The insolvency market has seen an increase in the number of insolvencies, fueling supply for insolvency portfolios [6][7] Company Strategy and Competitive Position - The company aims to maintain a strong focus on deploying capital for portfolio purchases at attractive risk-adjusted returns [20][22] - The company has improved its operational efficiency and has a robust funding structure, positioning it well for future opportunities [9][20] - The company intends to remain disciplined and opportunistic in M&A activities while focusing on organic growth [22] Management Commentary on Future Outlook - Management expressed confidence in the investment opportunity, citing favorable trends in consumer delinquencies and charge-offs [7][8] - The company anticipates that the Bluestem portfolio will significantly contribute to financial results in 2026 [4][19] - Management noted that the current economic environment is likely to be a net positive for supply-side opportunities [27][28] Other Important Information - The company completed a follow-on offering that improved liquidity and reduced ownership concentration [3] - A quarterly dividend of $0.24 per share was declared, representing a 4.7% annualized yield [22] - The company repurchased 3 million shares as part of a tactical strategy to support the follow-on offering [22] Q&A Session Summary Question: Thoughts on macro uncertainties affecting purchasing environment - Management indicated that while energy costs and employment changes may impact delinquencies, they do not foresee significant effects on liquidation rates [27][28] Question: Trends among sellers regarding forward flow deals - Management noted that about half of deployments have historically been in forward flows, but they do not target a specific percentage [30] Question: Expected efficiency ratio trends with portfolio changes - Management expects a substitution effect as the Conn's portfolio runs off, but anticipates maintaining a strong efficiency ratio through ongoing improvements [36] Question: Insights on supply increase and return profiles - Management stated that supply levels have been stable, and return profiles remain attractive with consistent pricing [48] Question: Characteristics of deployments and market shifts - Management highlighted an increase in deployments in insolvencies and noted that their geographic and asset class diversification continues to yield attractive returns [56] Question: Legal channel performance and profitability - Management confirmed that the volume of legal accounts aligns with underwritten expectations, and the growth in legal channel activity is consistent with their forecasts [93]

Financial Data and Key Metrics Changes - Net sales for Q4 2025 increased by 4.4% to $291.3 million compared to $279.2 million in Q4 2024, with comparable sales up 2.2% [12][17] - Full-year net sales for fiscal 2025 were $929.1 million, a 4.5% increase from $889.2 million in 2024, with comparable sales up 4.3% [17][19] - Gross margin for Q4 2025 was 38.2%, up from 36.2% in Q4 2024, driven by product margin improvement [15][19] - Operating income for Q4 was $25 million, or 8.6% of net sales, compared to $20.1 million, or 7.2% of net sales in the prior year [16][20] - Net income for Q4 was $19.6 million, or $1.16 per share, compared to $14.8 million, or $0.78 per share in the previous year [17][21] Business Line Data and Key Metrics Changes - Men's category led positive comparable sales growth during the holiday period, followed by women's, accessories, and hardgoods [4] - For the full year, women's was the largest positive comping category, followed by men's, hardgoods, and accessories, with footwear being the only negative comping category [18] Market Data and Key Metrics Changes - North America net sales for Q4 were $224.4 million, an increase of 4.8% from 2024, with comparable sales up 5.5% [12][13] - Other international net sales, which include Europe and Australia, were $66.9 million, up 3% from last year, but comparable sales declined 7.5% in Q4 [13][14] Company Strategy and Development Direction - The company is focused on three strategic priorities: driving revenue growth through consumer-focused initiatives, sustaining profitability optimization, and capitalizing on a solid financial foundation for strategic expansion [6][9] - The company launched over 150 new and emerging brands in 2025, with private label penetration reaching 30% of sales, up from 12% five years ago [7][8] - The company plans to open 5 new stores in 2026 while closing approximately 25 stores, including 20 in North America and 5 internationally [32][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to generate value despite economic volatility, emphasizing the effectiveness of strategic initiatives [10] - The company anticipates total sales growth in the low single digits for the year, despite the negative impact of closed stores worth approximately $12 million [30][32] - Management noted that ongoing volatility in the macro environment warrants caution, but they remain optimistic about maintaining positive momentum [29][30] Other Important Information - The company ended the year with cash and current marketable securities of $160.6 million, up from $147.6 million the previous year, with no debt on the balance sheet [21][22] - The company repurchased 2.7 million shares during fiscal 2025 at an average cost of $14.18 per share, totaling $38.3 million [23] Q&A Session Summary Question: What is the situation in Europe regarding comparable sales? - Management indicated that Europe is driving the performance, with a strategic shift towards full price selling leading to improved results [36][37] Question: Why is the company anticipating lower comparable sales performance for the remainder of the quarter? - Management noted softness in sales due to global conflicts and rising fuel prices, leading to a cautious outlook [44][45] Question: How is the private label performing compared to branded products? - Management stated that there were no significant changes in trends between private label and branded products, with both performing well [49][50] Question: What are the expectations for spring assortments and promotions around Easter? - Management is planning to take advantage of Easter with new assortments while maintaining a focus on full price selling [52][53] Question: What steps are being taken to stabilize international operations? - Management emphasized a focus on product assortment and customer connection to drive stability and growth in international markets [60][61]

Financial Data and Key Metrics Changes - Net sales for Q4 2025 increased by 4.4% to $291.3 million compared to $279.2 million in Q4 2024, with comparable sales up 2.2% [12][17] - Full-year net sales for fiscal 2025 were $929.1 million, a 4.5% increase from $889.2 million in 2024, with comparable sales up 4.3% [17][19] - Gross margin for Q4 2025 was 38.2%, up from 36.2% in Q4 2024, driven by product margin improvement [15][19] - Operating income for Q4 was $25 million, or 8.6% of net sales, compared to $20.1 million, or 7.2% of net sales in the prior year [16][20] - Net income for Q4 was $19.6 million, or $1.16 per share, compared to $14.8 million, or $0.78 per share in the previous year [17][21] Business Line Data and Key Metrics Changes - Men's category led positive comparable sales growth during the holiday period, followed by women's, accessories, and hardgoods [4][14] - Footwear was the only negative comping category [14][55] - Private label penetration reached approximately 30% of sales in 2025, up from 12% five years ago [7] Market Data and Key Metrics Changes - North America net sales for Q4 were $224.4 million, an increase of 4.8% from 2024, with comparable sales up 5.5% [12][13] - Other international net sales, which include Europe and Australia, were $66.9 million, up 3% from last year, but comparable sales declined 7.5% in Q4 [13][19] - For fiscal 2025, North America net sales were $757 million, a 5.1% increase from 2024, while other international net sales were $172 million, up 1.7% [18][19] Company Strategy and Development Direction - The company is focused on three strategic priorities: driving revenue growth through consumer-focused initiatives, optimizing profitability, and managing volatility while funding strategic expansion [6][9] - The commitment to refreshing the product mix with innovative offerings has been a cornerstone of success, with over 150 new brands launched in 2025 [7][8] - The company plans to open five new stores in 2026 while closing approximately 25 stores, including 20 in North America and five internationally [33][70] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to generate value despite economic volatility and evolving global dynamics [10] - The company anticipates total sales growth of 3%-5% for Q1 2026, with comparable sales expected to be between 2% and 4% [27][30] - Management highlighted the importance of maintaining operational discipline and delivering distinctive merchandise to drive growth [10][32] Other Important Information - The company ended the year with cash and current marketable securities of $160.6 million, up from $147.6 million the previous year [21][22] - The company repurchased 2.7 million shares during fiscal 2025 at an average cost of $14.18 per share, totaling $38.3 million [23] Q&A Session Summary Question: What is the situation in Europe regarding comparable sales? - Management indicated that Europe was the primary driver of the international comp performance, with a strategic shift towards full price selling showing positive results [36][37] Question: Why is the comp guidance for the quarter lower than current performance? - Management noted that while February was strong, there was observed softness in early March due to global conflicts and rising fuel prices [44][45] Question: How did private label perform compared to branded products during the holiday season? - Management stated that there were no significant changes in trends between private label and branded products, with both performing well [49][50] Question: What are the plans for store openings and closures? - Management confirmed plans to open five new stores while closing approximately 25, focusing on profitability and cash flow [67][70]

Financial Data and Key Metrics Changes - For the full year of 2025, the company generated $311.1 million in revenue and $41.4 million of Adjusted EBITDA, representing a 1% year-over-year growth [16][17] - In Q4 2025, total revenue was $74.7 million, down from $79.6 million in the prior year period [16][17] - Adjusted gross margin for Q4 was 53.5%, compared to 46.6% in the prior year [18] - Adjusted operating expenses for Q4 were $26.2 million, representing 35% of revenue, down from 37% in Q4 2024 [18][19] - The company incurred impairment charges on goodwill and intangible assets of $110.2 million during 2025, leading to a GAAP net loss of $178 million, up from a loss of $69.5 million in 2024 [19][20] Business Line Data and Key Metrics Changes - Technology revenue for Q4 was $51.9 million, while professional services revenue was $22.8 million, with the decline in professional services attributed to reduced FTE service offerings [17] - For the full year, technology revenue increased by 7% year-over-year to $208.3 million, while professional services revenue declined by 8% [17] Market Data and Key Metrics Changes - The company finished the year with 32 net new logos, ahead of the target of 30 but below the initial expectation of 40 [16] - The dollar-based retention rate for technology plus TAMS closed the year at 93% [16] Company Strategy and Development Direction - The company is focused on long-term success and is conducting a strategic review to position itself better for shareholder value [6][29] - There is a renewed emphasis on simplifying the commercial engine to drive technology ARR bookings and improve retention through predictable migrations [12][13] - The company aims to leverage its intellectual property and expertise in AI to differentiate itself in the market [12] Management's Comments on Operating Environment and Future Outlook - Management noted that the healthcare market is under pressure, with clients needing to manage costs while maintaining clinical quality [40] - The company is not providing full-year guidance for 2026 but expects Q1 revenue to be between $68 million and $70 million, with Adjusted EBITDA of $7 million to $8 million [21][22] - There are anticipated challenges related to the DOS to Ignite migration, with expected revenue declines due to downselling and churn [22][23] Other Important Information - The company is undergoing leadership changes, with a new CEO emphasizing a back-to-basics approach and a focus on core capabilities [6][9] - The company is reviewing its cost structure to ensure strategic capital allocation and is focused on expanding technology bookings and margins [9][12] Q&A Session Summary Question: Does the strategic review include the possibility of selling the company? - Management is focused on positioning the company for long-term success and creating shareholder value, but is currently in an assessment mode [29][31] Question: Can you elaborate on the transition impact regarding the $52 million in data platform revenue? - The $52 million encompasses both integrated applications and data platform infrastructure, with the latter facing the highest pressure during the migration [35][66] Question: What insights were gained regarding bookings and demand in Q4? - The market is in need of better cost management and clinical quality, which is reflected in the sales funnel and demand for the company's solutions [40] Question: How does the company plan to maintain client relationships amid potential downsells? - The company generally retains application relationships even when facing downsells in data platform infrastructure, focusing on client needs and expertise [49][66] Question: What is the expected impact of the DOS-related ARR churn on 2026? - Approximately 75% of the $12.5 million in ARR churn is expected to impact 2026, with negotiations ongoing to retain application relationships [65][66]

Financial Data and Key Metrics Changes - Total revenue for the full year 2025 was $185.3 million, down 2% year-over-year from $189.9 million in 2024 [10] - Advertising revenue declined 3% to $91.7 million, while programmatic advertising grew 7% to $69.6 million, representing 76% of total advertising revenue [10] - Adjusted EBITDA improved 61% to $8.8 million compared to $5.5 million in 2024 [11] - Net loss from continuing operations was $57.3 million compared to $34 million in 2024, reflecting a non-cash goodwill impairment charge of $30.2 million [11] Business Line Data and Key Metrics Changes - Studio revenue nearly tripled to $16.1 million, driven by the delivery of three feature films and contributions from the micro drama category [10] - Content revenue increased 9% to $37 million, while direct sold content declined 26% to $21 million [11] - Commerce and other revenue declined 8% to $56.5 million, with affiliate commerce declining 7% to $55.5 million [11] Market Data and Key Metrics Changes - Time spent totaled 276.5 million hours, down 7% year-over-year, expected due to elevated engagement during the presidential election cycle in 2024 [12] - Q4 revenue was $56.5 million, up 1% year-over-year, with advertising revenue increasing slightly to $25.6 million [14] - Programmatic advertising grew 2% to $18.4 million, while direct sold advertising declined 3% to $7.2 million [14] Company Strategy and Development Direction - The company believes it is undervalued, with the current market value not reflecting the strength of its individual brands and innovative work [4] - The focus is on closing the gap between market valuation and the intrinsic value of assets, particularly through new products and AI-driven experiences [9] - The company is exploring strategic options to unlock value and address liquidity challenges, with an update on strategic direction expected in the coming quarters [15] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by legacy costs and a pessimistic view of digital media, but believes in the potential of unlaunched products and forthcoming features [5] - The company is committed to demonstrating the value of its assets and innovative work, particularly in AI and new product experiences [8] - Guidance for 2026 is being withheld due to ongoing evaluations of strategic opportunities [15] Other Important Information - The company ended the year with cash and cash equivalents of approximately $27.7 million, a decrease of $10.9 million compared to 2024 [12] - Total debt as of December 31, 2025, was $60.2 million, with $45 million in term loans and $15.2 million in film financing arrangements [13] Q&A Session Summary - No specific questions or answers were provided in the content, thus this section is not applicable.

WM Technology (NasdaqGS:MAPS) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsDoug Francis - CEOSimon Yao - Director of Investor RelationsSusan Echard - CFOOperatorThank you for standing by and welcome to the WM Technology, Inc. fourth quarter and full year 2025 earnings call. I'd now like to introduce your host for today's program, Simon Yao. Please go ahead, sir.Simon YaoGood afternoon, and thank you for joining us to discuss our fourth quarter and full year 2025 results. Today we are ...

Financial Data and Key Metrics Changes - The company reported record collections of $245 million, an increase of 41% year-over-year [3][4] - Revenue for the quarter reached $155 million, up 30% compared to the prior year [4][17] - Adjusted EPS for the quarter was $0.69, reflecting strong financial performance [4] - The cash efficiency ratio was 71%, driven by strong collections from the Conn's portfolio purchase [4][16] - For the full year, the cash efficiency ratio was 74%, with a target leverage ratio of 2x-2.5x on a sustained basis [19][20] Business Line Data and Key Metrics Changes - Collections from the Conn's portfolio contributed $36 million for the quarter, while the Bluestem portfolio added $14 million [10] - The company achieved record deployments of $381 million, up 6% from the previous year [3][12] - Estimated remaining collections reached $3.4 billion, a 23% increase year-over-year [4][13] Market Data and Key Metrics Changes - Delinquency trends remain elevated across non-mortgage consumer asset classes, creating favorable portfolio supply trends [5][7] - Personal savings levels have decreased to $831 billion, significantly lower than pre-pandemic averages, indicating limited consumer ability to absorb financial hardships [6] - The insolvency market has seen an increase in the number of insolvencies in the U.S. and Canada, fueling a resurgence in supply of insolvency portfolios [6][7] Company Strategy and Development Direction - The company aims to solidify its leadership position as a strategic acquirer of dislocated consumer credit portfolios, with the Bluestem acquisition expected to contribute meaningfully to financial results in 2026 [4][19] - The focus remains on deploying capital to purchase portfolios at attractive risk-adjusted returns, with a disciplined approach to M&A [22] - The company has improved its operational efficiency and collection capabilities, which are expected to enhance net returns [9][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the investment opportunity, citing favorable supply conditions and strong collection performance [5][7] - The current economic environment is viewed as a net positive for supply, with no indications of impacting expected liquidation rates [27][28] - The company anticipates continued growth in legal collections due to increased inventory of suit-eligible accounts [12][18] Other Important Information - The company completed a follow-on offering post-IPO, improving liquidity and reducing ownership concentration [3] - A quarterly dividend of $0.24 per share was declared, representing a 4.7% annualized yield [22] - The company repurchased 3 million shares for $59 million as part of a tactical strategy to support the follow-on offering [22] Q&A Session Summary Question: Thoughts on macro uncertainties affecting purchasing environment - Management indicated that incremental pressures from energy costs and modest employment deterioration are likely to impact delinquencies but not liquidation rates [27][28] Question: Trends among sellers regarding forward flow deals - Management noted that about half of deployments have historically been in forward flows, but they do not target a specific percentage [30][31] Question: Expectations for cash efficiency ratio as portfolios run off - Management expects a substitution effect with the Bluestem portfolio, maintaining a cash efficiency ratio in the high sixties excluding certain collections [36] Question: Increase in supply of charged-off accounts - Management stated that the supply of elevated levels of charged-off accounts has been ongoing and is expected to continue [47] Question: Tax rate expectations for 2026 - The expected tax rate for 2026 is projected to be around 24.5% [49] Question: Current posture on share buybacks - Management indicated that the recent share repurchase was tactical, with a focus on deploying capital for portfolio purchases [51][52] Question: Characteristics of deployments and market shifts - Management highlighted an increase in deployments in insolvencies and a consistent pattern in other asset classes [56][57] Question: Legal channel returns and scaling opportunities - Management confirmed that the volume of legal accounts aligns with underwritten expectations, with no significant uncovered inventory impacting profitability [93]

Financial Data and Key Metrics Changes - Revenue for the 12-month period grew 12% year-over-year, reaching BRL 3,697 million, with adjusted EBITDA growth of over 50% year-over-year, reaching BRL 1,680 million [4][5] - Adjusted EBITDA margin for the same period reached 45.4%, an increase of 130 basis points over last year [4][25] - Net income reached BRL 768.4 million, an 18% growth year-over-year, with basic EPS reaching BRL 8.32, a 19% increase compared to last year [5][26] - Cash flow from operating activities ended the 12-month period at BRL 1,548 million, over 6% higher than last year, with a cash conversion of 93.7% [4][25] Business Line Data and Key Metrics Changes - The number of undergraduate medical students grew by 5% year-over-year, reaching over 25,000 students, with approved medical seats increasing by 5% [19] - Continuing education segment revenue grew by 11% year-over-year, reaching BRL 284 million, with B2B revenue growth at 48% [7][20] - Medical practice solutions revenue increased by 6% year-over-year, reaching BRL 171 million [7][23] Market Data and Key Metrics Changes - The ecosystem reached 301,000 active users, reflecting strong engagement among physicians and medical students across Brazil [7][9] - The number of active payers in medical practice solutions reached 196,000, with physicians making over 16.9 million prescriptions using the solutions [9][23] Company Strategy and Development Direction - The company aims to strengthen its position across the entire physician lifecycle, expanding its audience and deepening engagement [11][12] - Investments will focus on integrating products and services for physicians, enhancing the user experience, and creating a unified platform [36][37] - The company plans to maintain a balanced capital allocation strategy, focusing on sustainable cash generation, growth investments, and shareholder returns [10][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving another strong year in 2026, with revenue guidance between BRL 3.95 billion and BRL 4.1 billion [16][17] - The company does not expect any material impact from ENAMED on its 2026 guidance, with preparations in place for upcoming evaluations [17][46] - Management highlighted the importance of integrating technology and enhancing product offerings to drive future growth [36][37] Other Important Information - A cash dividend of BRL 307.4 million was announced, representing 40% of the 2025 net income, payable in April 2026 [10][11] - The company maintains a conservative leverage profile with a net debt of BRL 1,369 million, a reduction of BRL 445 million from the end of 2024 [29] Q&A Session All Questions and Answers Question: Focus on continuing education and medical practice solutions transformation - Management discussed integrating products and services for physicians under a unified platform, enhancing user experience and audience engagement [36][37] Question: Progress on ENAMED and PROFIMED discussions - Management indicated no expected impact from ENAMED on 2026 guidance and detailed preparations for upcoming evaluations [46][48] Question: Operational expenses and CapEx increase - Management explained that the increase in intangible assets was due to new investment programs initiated in Q4 2025, and operational expenses were managed effectively [55][56] Question: Capital allocation priorities - Management emphasized the flexibility in capital allocation due to strong free cash flow, focusing on M&A, dividends, and share buybacks [62][63] Question: Revenue growth breakdown by segment - Management provided insights that undergraduate growth would be in single digits, while continuing education and SPM segments would see double-digit growth [75]